![](https://cdn.sanity.io/images/0vv8moc6/genetherapy/dd62988d69179707b1cb54323714832404506997-300x300.jpg?fit=crop&auto=format)
Low-Dose Gene Therapy Well-Tolerated, Shows Some Trends of Improvement for Cystic Fibrosis
4D-710, 4D Molecular Therapeutics’ (4DMT) gene therapy candidate for treating cystic fibrosis (CF), has demonstrated CFTR transgene RNA and protein expression in all 10 participants whose disease is ineligible for or cannot tolerate approved CF modulator …